HomePharmaceuticals

Pharmaceuticals Market Research Reports & Consulting

discount on Mnm

Market Reports


Title Published Price TOC Available

Freeze Drying / Lyophilization Equipment Market by Scale (Lab, Pilot, & Industrial), Technology (Rotary, Manifold, & Tray - style) & by Accessories (Loading/Unloading System, Vacuum System, Clean-in-Place System, Control System) - Global Forecast to 2019

Freeze drying is an efficient method for drying various unstable, heat sensitive, aqueous products in various industries. In the healthcare industry, freeze drying is mostly used in pharmaceutical and biotech manufacturing.

September 2014 $ 4650 selected

Cleanroom Technology Market by Equipment (HVAC System, HEPA Filter, Air Shower, Air Diffuser), Consumables (Apparel, Gloves, Wipes, Disinfectants), Construction (Hardwall, Softwall), & by End User (Pharmaceutical, Biotech) – Global Forecast to 2019

Over the years, the demand for cleanrooms for healthcare industry has increased significantly owing to the stringent healthcare regulations, emergence of biologics, growing pharmaceutical industry, and rising application of cleanrooms in medical device industry. Further, the growing healthcare industry in the developing regions such as China and India would provide extensive growth opportunities for the cleanroom technology market. However, high cost associated with installation and use of cleanrooms would be restraining the growth of healthcare cleanrooms market during the forecast period to a certain extent.

September 2014 $ 4650 selected

Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019

The global human insulin market is estimated to reach $42 billion by 2019, at a CAGR of 12.5% from 2014-2019.The market will be driven by rising prevalence of diabetes worldwide, spiralling aging population that increases the incidences of diabetes, growing obese population due to the change in lifestyle, favorable government initiatives, and introduction of pen device that delivers human insulin efficiently and effectively. However, the regulatory environment for approving biotechnology derived drugs is more complex and stringent in U.S.

July 2014 $ 4650 selected

Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018

The global animal antimicrobials and antibiotics market is valued at $3,340.8 million in 2013 and is estimated to reach $4,143.4 million by 2018. The rising demand for animal protein products in the emerging countries and the increasing trend for companion animal ownership are some of the factors driving the growth of this market.

May 2014 $ 4650 selected

Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour On, Spot On, Collars, Ear Tags), Animal (Dogs, Cats, Cattle, Pigs, Sheep & Goats) - Global Forecast to 2018

Over the years, the demand for animal parasiticides has increased significantly owing to the growing awareness about zoonotic diseases; implementation of animal welfare acts in developed countries; increase in the population of livestock animals, especially in the emerging markets; launch of new broad spectrum parasiticide product offerings by leading players; increasing demand for animal protein and animal-based food; and an upsurge in the animal welfare awareness leading to the worldwide adoption of companion animals such as cats and dogs

May 2014 $ 4650 selected

Animal Growth Promoters and Performance Enhancers Market by Segment (Antibiotics, Growth Hormones, Feed Enzymes, Organic Acids, Probiotics and Prebiotics, â-Agonists, Phytogenics), by Animals (Porcine, Poultry, Aquaculture) - Global Forecasts to 2018

The global animal growth promoters and performance enhancers market is segmented on the basis of products, animal industry, and geography. Based on products, the growth promoters market comprises of antibiotics, hormonal growth promoters, â-agonists, feed enzymes, probiotics and prebiotics, organic acids, phytogenics, and others.

April 2014 $ 4650 selected

Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020

The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. The allogeneic stem cell therapy is expected to command the largest share of the stem cell therapy market in 2015, and the allogeneic stem cell therapy segment is expected to grow at the highest CAGR of 40% in the forecast period (2015-2020).

April 2014 $ 4650 selected

Packaging Equipment Market for Pharmaceutical by Product Type (Tablet, Powder, Cream, Syrup, Aseptic Liquid, Aerosol), Package Type (Blister, Strip, Bottle, Tube, Aseptic Packaging, Wrapping, Labeling & Serialization) - Global Forecast to 2018

The pharmaceutical packaging equipment industry has evolved from traditional packaging systems to modern automated, integrated, and flexible packaging lines to meet patient compliance requirements and anti-counterfeit measures in the pharmaceutical packaging equipment market. Safety and quality of packaging have also gained greater importance in pharmaceutical packaging over the years.

February 2014 $ 4650 selected

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – (Pipeline Forecast & Market Forecast in G8 Countries) (2011 – 2020)

The incidence of acute lymphocytic leukemia is high in children from 0 to 14 years than the people aged above 14. It is the most common childhood acute lymphocytic leukemia. However, the acute lymphocytic leukemia may also occur in adults. Acute lymphocytic leukemia distribution depends on age. For instance, 30% of is diagnosed before the age of 5 and 55% of ALL age 15.The acute lymphocytic leukemia market is segmented into two types; namely childhood acute lymphocytic leukemia, and adult acute lymphocytic leukemia. The market was dominated by Hyper-CVAD regimen in 2010. However, in 2020, the market is expected to be equally dominated by Hyper-CVAD and Linker regimen.

December 2013 $ 4650 selected

Leukemia Therapeutics Market (Acute/Chronic Lymphocytic Leukemia & Acute/Chronic Myeloid Leukemia) Pipeline Forecast & Market Forecast in G8 Countries - Global Forecast to 2020

Leukemia is the type of blood cancer and the ninth most common one in males. It accounts for almost 0.0148% of all the men and 0.009% of all the women worldwide. The leukemia market is segmented into four types; namely acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The market was dominated by chronic myeloid leukemia in 2010. However, in 2020, the market is expected to be equally dominated by acute lymphocytic leukemia and chronic myeloid leukemia.

November 2013 $ 6500 selected

Pharmaceutical Excipients Market by Products (Carbohydrates, Oleochemicals, Petrochemicals, Polymers, Microcrystalline Cellulose, Sugar, Calcium carbonate) & by Functionality (Fillers, Binders, Lubricants, Preservatives) – Global Forecast to 2018

The pharmaceutical excipients market has a high-growth potential because a majority of the drugs are going off-patent in the forecast period, which in turn leads to an increase in demand for pharmaceuticals for generics products. In contrast, the stringent regulations appear to restraint the growth of the overall market to a certain extent.

October 2013 $ 4650 selected

North America Weight Loss /Obesity Management Market – [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] – Forecasts to 2017

Obesity and weight gain have always been major concerns regarding the health and fitness of individuals; today, it has reached the level of an epidemic. Increasing obesity rate and increasing levels of awareness amongst calorie-conscious consumers in North America have opened new avenues for the weight management industry.

July 2013 $ 4650 selected

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017

The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012.

May 2013 $ 4650 selected

Weight Loss & Obesity Management Market – [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, Stomaphyx] - Global Forecasts To 2017

The weight loss & obesity management market is divided into three major segments, namely diets (foods, beverages, & supplements), services, and fitness and surgical equipment; the market is forecast till 2017. Global rise in obesity and chronic diseases are stimulating the growth of the market.

May 2013 $ 4650 selected

North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017

The North American radiopharmaceuticals market was valued at $1.9 billion in 2012 and is poised to reach $2.7 billion by 2017 at a CAGR of 7.2%.

April 2013 $ 4650 selected

European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Trends & Forecast to 2017

The European radioisotopes market was valued at $1.1 billion in 2012 and is poised to reach $1.6 billion in 2017 at a CAGR of 6.8%. A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as Europe, and other developed regions between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer’s disease, Parkinson’s disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 and OSIRIS in France in 2018 is, however, a major threat for manufacturers

April 2013 $ 4650 selected

Nuclear Medicine Market & Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast to 2017

A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as Europe, North America, Japan, the Republic of Korea, and Oceania between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer’s disease, Parkinson’s disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 and OSIRIS in France in 2018 is, however, a major threat for manufacturers.

April 2013 $ 4650 selected

Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)

Epigenetics, the scientific study of heritable changes in genome function and gene expression had opened the new gate of biology to understand the basis of diseases and presents incredible opportunities for drug discovery.

January 2013 $ 4650 selected

Smart Pills Technologies Market (2012 – 2017) (Diagnostic Imaging, Patient Monitoring, Drug Delivery)

Gastro-Intestinal (GI) disorders are becoming more prevalent in our day to day life owing changing lifestyles, dietary habits and aging population. The effective therapeutics and sources or unknown causes of bleeding for some of the GI disorders are still an enigma to the medical industry due to lack of effective medical devices that reach the contours of small intestine. Although there are flexible endoscopes, they still cause discomfort to the patients due to insertion of wired tube into the body. The advancements in the field of medical science and technology and the emergence of micro and nanotechnology have paved the way for miniaturized wireless capsule endoscopes, also called as capsule endoscopes. These micro capsules can also be used for site-specific drug delivery and effective patient monitoring. This novel approach, enabled by Bio-MEMS is called as Smart Pills. This technology is not only comfortable for patients, but also enables the healthcare providers to take on-time remedical action effectively.

October 2012 $ 4650 selected

Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 – 2017)

Biosimulation refers to computer aided simulation of biological processes and systems, an integral part of systems biology used in drug discovery and development. This report will analyze the potential of biosimulation in drug discovery and development. Biosimulation is used across the drug discovery and development program (such as target identification, target validation, lead discovery, lead optimization, preclinical and clinical test).

October 2012 $ 4650 selected

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)

Autologous cell therapies are new therapeutic intervention where it introduces or uses cells or tissues from the individual, cultured, expanded and re-introduced at the site of the disease of the donor. They are widely promoted as next pillar or advancement in medical care.

October 2012 $ 4650 selected

U.S. General Anesthesia Drugs Market (2011 - 2015) - Market Entry Strategy (Propofol, Midazolam, Diazepam, Fospropofol Disodium, Sodium Pentothal, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate and Fentanyl)

Anesthesia is a condition in which sensation is totally or partially blocked. This enables the patients to undergo medical procedures and surgery. Based on the applications (type of surgery or medical procedure) anesthetic drugs are broadly categorized into two types; i.e. local anesthetic drugs and general anesthetic drugs. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation.

May 2012 $ 4650 selected

Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020)

Chronic lymphocytic leukemia is the second most common cancer in adult males and rarely occurs in children. The risk of chronic lymphocytic leukemia is closely associated with age. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age. The chronic lymphocytic leukemia market is segmented into two types; namely childhood chronic lymphocytic leukemia and adulthood lymphocytic leukemia. The market was dominated by Campath drug in 2010. However, in 2020, the market is expected to be equally dominated by GA101/RG7159 molecule and Arzerra drug.

December 2011 $ 4650 selected

Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016)

The Development in the High Potency Active Pharmaceutical Ingredient (HPAPI) and Biogeneric drugs is boosting the growth of the Active Pharmaceutical Ingredient (API) market. There has been a paradigm shift in the use of innovative drugs to that of low-cost API drugs after the economic recession, thereby causing a positive impact on the overall growth of the API market. In order to keep abreast with this change, API manufacturers are applying various novel technologies to reduce the processing time in order to yield more production.

December 2011 $ 5650 selected

Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)

Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.

November 2011 $ 5650 selected

Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries

Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.

November 2011 $ 4650 selected

Global Clinical Trials Market (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)

This research report categorizes the Global Clinical Trials Market on the basis of phases, indications, and study design analyzing trends in each. Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 20 company profiles.

September 2011 $ 4650 selected

Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015)

The lung cancer surgery market is expected to grow at a CAGR of 4.9% during the study period (2010-2015). Thoracotomy is the most widely used surgical procedure for lung cancer treatment accounting for about 74% of all surgical interventions.

June 2011 $ 4650 selected

Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) (2010 – 2015)

This market research report analyzes the diabetes care devices market in Brazil, Russia, India, and China (BRIC) over the period 2010-2015. The report categorizes the overall market for diabetes care devices into the submarkets for insulin pumps, self-monitoring blood glucose systems, and continuous glucose monitoring systems.

April 2011 $ 4650 selected

Worldwide Dermatology Devices Market (2010-2015)

The dermatology devices studied and segmented in this report are as per their usage in the diagnosis and treatment of skin related disorders such as skin cancer (melanoma and non-melanoma), psoriasis, acne, scars, and others. The diagnostic devices analyzed are dermatoscopes, microscopes, imaging techniques such as MRI, CT and Optical Coherence Tomography (OCT) scanners. The total market for diagnostic devices was estimated to be $175 million in 2010, and is expected to grow at a CAGR of 7.3% from 2010 to 2015.

March 2011 $ 4650 selected

US Neonatal (Preterm) Infant Care Market (2010-2015)

Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market.

March 2011 $ 4650 selected

Global Weight Loss & Diet Management Products & Services Market (2010 - 2015)

Obesity and weight gain issues have always been major concerns impacting the health and fitness of the individuals. Increasing levels of awareness amongst the calorie conscious consumers have opened up new avenues and opportunities in this market.

February 2011 $ 4650 selected

Global Anesthesia and Respiratory Devices Market (2010-2015)

The global anesthesia and respiratory devices market is expected to witness moderate growth in the coming five years. Respiratory devices account for the largest share (about 57%) in this market; primarily due to their wide usage among the three consumer segments (healthcare institutions, home healthcare and transport) as compared to anesthesia devices; which have limited usage amongst the end-users.

February 2011 $ 4650 selected

Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market

The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.

February 2011 $ 4650 selected

Pharma & Healthcare Social Media Marketing Strategies

Increasing number of web users’ world wide (1.8 billion), development and popularity of web based community sites (Twitter, Facebook), tools and information centers (branded & unbranded sponsored communities) are changing approach towards Pharma and healthcare marketing and information sharing. In pharma industry social media has emerged as an effective tool for marketing, consumer engagement, monitoring & analyzing user generated content and building & changing brand perception. Social media is emerging as a strategic shift in organizations communication and operation model. Top pharmaceutical market players have started integrating social media in to their marketing mix. The effective social media marketing strategies that can help generate business exposure, market research data, relationship building and thus can prove as an important initiative to boom sales and overall business in the long term

August 2010 $ 4650 selected

Global Cancer Biomarkers Market (2010 - 2015)

Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market.

June 2010 $ 4650 selected

BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China

The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.

April 2010 $ 4650 selected

Opportunity Analysis of H1N1 (swine flu) Vaccination Market

The increase in public awareness and government initiatives, as a consequence of scare from pandemic flu has resulted in the drastic rise in demand for the Influenza Vaccines. This transient boost in demand of seasonal influenza vaccines is an impact of prevailing H1N1 pandemic, due to apprehension and lack of clarity among the general public. The emerging technologies in production are going to give a new face to the market dynamics of this market. The upcoming vaccines and drugs by various players in the market such as Novartis’ Optaflu and ProteinSciences’ FluBlock, along with the emerging technologies in production are going to give a new face to the market dynamics of this market.

November 2009 $ 4650 selected

Autoimmune Treatment Market (2009 - 2014)

The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market.

September 2009 $ 4650 selected

Global Weight Loss and Diet Management Market (2009 - 2014)

Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition.

July 2009 $ 4650 selected



Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us


Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support



US : 1-888-600-6441
UK : 44-800-368-9399

Search reports